PHM: Hold + Reduce with a $101.98 price target

Capital earns more than at peers, but the profit margin narrowed.

Target for 2027-09-17: $101.98 USD, -13.8% versus the $118.26 weekly close on 2026-09-11. Price return only; dividends, fees and tax excluded.

Over 1 year (2025-09-12 to 2026-09-11), price changed -13.7% and trailing EPS changed -24.4%. A wider gap changes the earnings multiple; it does not establish fair value.

Return on invested capital: 13.1% for PHM, against 10.5% across 12 comparable peers.

Net debt / EBITDA: 0.4× for PHM, against 1.2× across 12 comparable peers.

The latest quarterly operating margin was 11.1%, -7.2 percentage points from a year earlier. The full report separates sales growth from margin changes.

Across 2 completed quarters since 2025-12-31, net income was 819.0m versus 1,131.3m in the matching prior-year periods (USD). Check whether the latest quarter changes that direction.

The latest quarterly margin changed -7.2 percentage points from a year earlier. Check sales volumes, pricing and unusual gains in the next filing.

Recheck the valuation gap alongside profitability and growth after new results. A discount alone does not establish value.

Compare the stock and the market fund over the same dates. Look for a change in relative performance as results arrive.

Starting annual sales growth: -7.94%.

Net profit margin: 13.91%.

Review recorded on 2026-09-17. This is a dated summary of an automated company valuation. The full report includes the financial evidence, alternative scenarios and review history. Consult the latest report before using an earlier target. Automated model research, not personal investment advice. Targets depend on assumptions; returns are not guaranteed.